ArticleAvicenna journal of phytomedicine2026
Attenuation of diabetes linked testicular co-morbidity by
Article in Avicenna journal of phytomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The study demonstrated the management efficacy of Materials and Methods: Healthy and fertile rats were allowed for diabetes induction by streptozotocin injection at 40 mg dose/kg of somatic weight. Diabetic rats were treated for 28 days at 10, 20, 40 mg doses of hydro-ethanol (40:60, v/v) extract of Results: Glucose-6-phosphate dehydrogenase, antioxidant and key androgenic enzyme activities, serum testosterone level and values of sperm parameters were diminished, confirming testicular co-morbidity in diabetes. Simultaneously, fasting blood sugar level, glucose-6-phosphatase activity, seminal vesicular fructose, testicular cholesterol, lipid peroxidation metabolite's level and toxicity sensors were elevated in diabetic group. Significant amelioration (p < 0.05) in these parameters along with improved gene expression of testicular Δ Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.